Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
John Militello, VP, Principal Accounting Officer, and Interim Principal Financial Officer of Rocket Pharmaceuticals, sold 2,490 shares of common stock on March 21, 2024, to cover tax obligations related to RSU vesting.
Summary
- John Militello, an officer at Rocket Pharmaceuticals, sold 2,490 shares of common stock on March 21, 2024, at a price of $28.104 per share.
- The sale was executed to cover tax obligations associated with the vesting of Restricted Stock Units (RSUs).
- Militello also updated his filing history to include RSUs on Table I, in accordance with SEC guidance.
- The filing indicates that Militello directly owns 55,239 shares of Rocket Pharmaceuticals common stock following the transaction.
Sentiment
Score: 5
Explanation: The document reflects a routine transaction related to executive compensation and does not convey any particularly positive or negative sentiment about the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of RSUs are a common practice among company executives. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the executive's confidence in the company.
Comparison to Industry Standards
- Executive compensation packages in the biotechnology industry often include stock options and restricted stock units (RSUs) as a way to align the interests of management with those of shareholders.
- The vesting schedules and tax implications of these equity awards are generally similar across companies in the sector.
- Comparable companies such as Bluebird Bio, CRISPR Therapeutics, and Beam Therapeutics also see similar patterns of stock sales by executives to cover tax liabilities related to equity compensation.
Stakeholder Impact
- The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect on shareholders.
- The transaction does not directly impact employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 02/14/2022 | Initial grant date of Restricted Stock Units (RSUs) that vest over time. |
| 04/18/2022 | Grant date of Restricted Stock Units (RSUs) that vest over time. |
| 08/12/2022 | Grant date of Restricted Stock Units (RSUs) that vest over time. |
| 02/14/2023 | Grant date of Restricted Stock Units (RSUs) that vest over time. |
| 03/21/2024 | Date of the stock sale transaction to cover tax obligations. |
| 03/25/2024 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.